IQGAP3 promotes the progression of glioma as an immune and prognostic marker

Conclusion: IQGAP3 shows promise as a valuable biomarker for diagnosis, prognosis, and immunotherapeutic strategies in gliomas.PMID:38560572 | PMC:PMC10972721 | DOI:10.32604/or.2023.046712

Source: Oncology Research - April 1, 2024 Category: Cancer & Oncology Authors: Xiaofeng Gao Juanjuan Ge Xuzheng Gao N A Mei Yanting Su Shigang Shan Wenbin Qian Jiangheng Guan Zhenwang Zhang Long Wang Source Type: research